Skip to content
arXiv Robotics — research abstracts· Mohammad H. Mahoor, Matthew Hessler, Lombe Chileshe, Ola Alsaadi, Eshrat Emamian, Kerstin S. Haring, Richard M. Voyles·· 1 days agoSignalEditorial score75

Wellness Robots and the Path to Full Autonomy

Wellness Robots and the Path to Full Autonomy

Summary

This paper defines autonomous wellness robots using a six-level Care Robot Autonomy Scale (CRAS) modeled on SAE J3016. It presents Ryan, developed at the University of Denver and commercialized by DreamFace Technologies, as a case study. NIH/NIA-funded data (N=18; 887 hours) reports statistically significant cognitive improvement (SLUMS +2.61, p = 0.015) and a trend toward reduced depressive symptoms (PHQ-9 -2.50, p = 0.073).

Editorial context

The authors introduce a new taxonomy (CRAS) and present longitudinal data from an NIH-funded study on the Ryan robot, while explicitly distinguishing current capabilities (CRAS Level 1-2) from future autonomy goals.

Source: arXiv Robotics — research abstracts · Read original article ↗

Loading article text…

What the source reports

Publisher-reported claims, with original evidence. These results have not been independently verified by RoboSignal.

Reported numbers

  • Reported duration

    887 hours

    View original evidence
    across four wellness-aligned dimensions. We present Ryan, developed initially at the University of Denver and commercialized by DreamFace Technologies, as a case study. NIH/NIA-funded longitudinal evidence (N = 18; 887 hours) shows statistically significant cognitive improvement (SLUMS +2.61, p = 0.015) and a clinically meaningful directional reduction in depressive symptoms (PHQ-9 -2.50, p = 0.073), with no novelty
    Open source S3
  • paper: not_reported
Source excerpts and review record

Automatically extracted; no manual editorial approval recorded.

across four wellness-aligned dimensions. We present Ryan, developed initially at the University of Denver and commercialized by DreamFace Technologies, as a case study. NIH/NIA-funded longitudinal evidence (N = 18; 887 hours) shows statistically significant cognitive improvement (SLUMS +2.61, p = 0.015) and a clinically meaningful directional reduction in depressive symptoms (PHQ-9 -2.50, p = 0.073), with no novelty

Open source S3

Source:arXiv Robotics — research abstracts · arxiv.org

Timezone · UTC

Article dates follow your selected timezone. Briefing editions use Hong Kong time (UTC+8).